A hot biotech that may be the next Genentech
May 12, 2015 at 07:00 AM EDT
This company has raised $1 billion to develop the Holy Grail in drugs: having the body's own cells churn out proteins to fight disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|